In Brief: General and Plastic Surgery Devices Panel
This article was originally published in The Gray Sheet
General and Plastic Surgery Devices Panel: Slated to meet Jan. 29 to review Organogenesis' premarket approval application for its Apligraf living dual-layered skin equivalent in treating venous leg ulcers. On the same day, the panel will review a PMA for use of Advanced Tissue Sciences' Dermagraft bioengineered living human dermal tissue for treatment of diabetic foot ulcers. On Jan. 30, a PMA for Closure Medical's Dermabond topical tissue adhesive intended for wound closure is on the agenda...
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.